FPAS
IRWD icon

Focus Partners Advisor Solutions’s Ironwood Pharmaceuticals IRWD Stock Holding History

Focus Partners Advisor Solutions’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Buy
62,072
+2,455
+4% +$10.1K ﹤0.01% 1123
2025
Q4 		$201K Buy
59,617
+7,322
+14% +$19K ﹤0.01% 1031
2025
Q3 		$113K Buy
52,295
+12,552
+32% +$13K ﹤0.01% 1093
2025
Q2 		$28.5K Buy
39,743
+29,409
+285% +$23.1K ﹤0.01% 1087
2025
Q1 		$15.2K Buy
+10,334
New +$24.6K ﹤0.01% 965

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Focus Partners Advisor Solutions's IRWD Position: Q1 2026 in Review

Focus Partners Advisor Solutions increased its Ironwood Pharmaceuticals (IRWD) stake by 4.1% in Q1 2026, buying an estimated $10.1K and bringing the position to 62,072 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Focus Partners Advisor Solutions first reported a position in IRWD in Q1 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Focus Partners Advisor Solutions held 62,072 shares of Ironwood Pharmaceuticals worth $218K as of Q1 2026.
  • Focus Partners Advisor Solutions bought 2,455 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $10.1K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #1123 holding.
  • Focus Partners Advisor Solutions first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.